Brokerages Set TransMedics Group, Inc. (NASDAQ:TMDX) Target Price at $122.70
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eleven ratings firms that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating […]
More Stories
Oppenheimer Asset Management Inc. Acquires 3,962 Shares of Intel Corporation (NASDAQ:INTC)
Oppenheimer Asset Management Inc. increased its stake in Intel Corporation (NASDAQ:INTC – Free Report) by 2.7% in the 1st quarter,...
Meta Platforms, Inc. (NASDAQ:META) Shares Acquired by Brown Lisle Cummings Inc.
Brown Lisle Cummings Inc. boosted its holdings in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 8.1% in the first...
Spinnaker Investment Group LLC Has $582,000 Position in Meta Platforms, Inc. (NASDAQ:META)
Spinnaker Investment Group LLC raised its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 41.7% during...
The J. M. Smucker Company (NYSE:SJM) Shares Sold by Kentucky Retirement Systems Insurance Trust Fund
Kentucky Retirement Systems Insurance Trust Fund trimmed its stake in shares of The J. M. Smucker Company (NYSE:SJM – Free...
Food Independence Summit Teaches a Return to Self-Sufficient Roots
By Jeff Louderback WALNUT CREEK, Ohio—Decades ago, many Americans knew the origin of their food. They lived in rural areas,...
Meta Platforms, Inc. (NASDAQ:META) is Oppenheimer & Co. Inc.’s 6th Largest Position
Oppenheimer & Co. Inc. raised its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 2.7% during...